Screener
Exelixis EXEL Business Segments — Drug discovery
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept exel:DrugDiscoveryCosts.
The source filing: Exelixis’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0000939767-26-000098
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues | $628,690 | $568,261 | $1,239,502 | $1,123,708 |
| Less: | ||||
| Cost of goods sold | 20,657 | 19,470 | 40,610 | 38,642 |
| Drug discovery | 18,252 | 21,357 | 37,728 | 39,610 |
| Development | 150,522 | 134,159 | 286,237 | 287,376 |
| Selling, general, and administrative | 127,413 | 112,931 | 250,283 | 233,706 |
| Other segment items(1) | 63,378 | 66,718 | 124,616 | 124,134 |
| Interest income | (14,210) | (16,789) | (30,337) | (35,865) |
Item 1. Financial Statements.
FAQ
- What is Exelixis's business segments — drug discovery?
- Exelixis (EXEL) reported business segments — drug discovery of $18.25M in Q2 2026.
- How has Exelixis's business segments — drug discovery changed year-over-year?
- Exelixis's business segments — drug discovery decreased by 14.5% year-over-year, from $21.36M to $18.25M.
- What is the long-term trend for Exelixis's business segments — drug discovery?
- Over 3 years (2022 to 2025), Exelixis's business segments — drug discovery has grown at a -28.9% compound annual growth rate (CAGR), from $249.71M to $89.93M.
- What does business segments — drug discovery mean?
- Refers to the early-stage research and development expenditures focused on identifying and validating new molecular entities. This investment is critical for maintaining a long-term pipeline of potential future therapies.
Ask your AI about Exelixis's business segments — drug discovery.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude